deeptech Value proposition
A new player committed to tackle #glioblastoma and #brain #cancer
Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma.
Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma.
Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.
Advancing cancer therapies. At the speed of light.
Advancing cancer therapies with Hemerion Therapeutics' innovative technology to fight brain cancer and glioblastoma.
https://hemerion.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Retis Government Administration | Retis Government Administration | Other 12 Apr 2024 | | |
 Agence pour la Valorisation de la Recherche Universitaire du Limousin (AVRUL) Research, Research Services | Agence pour la Valorisation de la Recherche Universitaire du Limousin (AVRUL) Research, Research Services | Other 12 Apr 2024 | | |
 | Réseau SATT | Other 7 Apr 2024 | | |
 | LUTECH | Other 7 Apr 2024 | | |
 | Aquitaine Science Transfert (SATT Aquitaine) | Other 7 Apr 2024 | | |
 | SATT AxLR | Other 7 Apr 2024 | | |
 Métropole Européenne de Lille (MEL) Government Administration, French metropolis | Métropole Européenne de Lille (MEL) Government Administration, French metropolis | Other 11 Apr 2024 | | |
 PULSALYS Research, Research Services | PULSALYS Research, Research Services | Other 7 Apr 2024 | | |
 La French Tech Lille French Tech, IT Services and IT Consulting | La French Tech Lille French Tech, IT Services and IT Consulting | Other 11 Apr 2024 | | |
 SATT CONECTUS Research, Research Services | SATT CONECTUS Research, Research Services | Other 7 Apr 2024 | | |